Fortis Malar Hospitals Limited has received an Income Tax rectification order with an additional demand of ₹48,22,435 for assessment year 2018-19. The company disclosed this development to the stock exchanges under SEBI listing regulations on March 25, 2026.

Tax Order Details

The Income Tax rectification order was dated March 19, 2026, and pertains to assessment year 2018-19. The company received the order on March 24, 2026, at 2:51 PM, as communicated in its regulatory filing.

Company's Response and Impact Assessment

Fortis Malar Hospitals has stated that based on its assessment, the demand is not maintainable. The company is working on filing an appeal against the Income Tax order. Management has indicated that it does not envisage any material impact on the company's financials, operations, or other activities due to this demand.

Regulatory Compliance

The disclosure was made in continuation of an earlier intimation dated April 1, 2025, and pursuant to Regulation 30 read with Schedule III of the SEBI Listing Obligations and Disclosure Requirements Regulations 2015. The company provided details as per SEBI Master Circular number HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.

The filing was signed by Vinti Verma, Company Secretary and Compliance Officer, with membership number A44528, and submitted digitally on March 25, 2026.

Fortis Healthcare Limited has filed its mandatory compliance report with both BSE Limited and National Stock Exchange regarding the status of physical share transfer re-lodgement requests for January-February 2026. The healthcare company submitted the report on March 16, 2026, in accordance with SEBI circular requirements for the special window facility.

Compliance Report Overview

The report was prepared by the company's registrar and share transfer agent, KFin Technologies Limited, and covers two distinct reporting periods under separate SEBI circulars. Company Secretary and Compliance Officer Satyendra Chauhan submitted the documentation to both stock exchanges, referencing BSE scrip code 532843 and NSE symbol FORTIS.

The compliance filing addresses SEBI Circular No. SEBI/HO/MIRSD/MIRSD-PoD/P/CIR/2025/97 dated July 2, 2025, and HO/38/13/11(2)2026-MIRSD-POD/I/3750/2026 dated January 30, 2026, which established special windows for re-lodgement of transfer requests for physical shares.

January 2026 Period Results

For the period from January 1, 2026, to January 6, 2026, KFin Technologies Limited reported complete absence of activity regarding physical share transfer requests:

February 2026 Monthly Status

The February 2026 reporting period showed identical results, with no shareholder requests received for re-lodgement of physical share transfers:

Regulatory Framework

The special window facility was established by SEBI to provide shareholders with an opportunity to re-lodge transfer requests for physical shares that may have been previously rejected or pending. The regulatory framework requires listed companies to maintain detailed records and submit periodic reports through their registrar and share transfer agents.

KFin Technologies Limited, serving as the registrar and share transfer agent, operates from its registered office in Mumbai and operations centre in Hyderabad. The company maintains comprehensive documentation and reporting systems to ensure compliance with SEBI requirements for share transfer activities.

Corporate Communication

The filing demonstrates Fortis Healthcare Limited's commitment to regulatory compliance and transparent reporting practices. The company maintains its registered office at Fortis Hospital, Sector 62, Phase VIII, Mohali, and corporate office at Tower-A, Unitech Business Park, Gurgaon, continuing to fulfill all statutory obligations regarding shareholder services and corporate governance requirements.